{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:14:36Z","timestamp":1789071276666,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.7759\/cureus.33175","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T15:08:40Z","timestamp":1672499320000},"source":"Crossref","is-referenced-by-count":5,"title":["The Role of Immune Mechanisms, Inflammatory Pathways, and Macrophage Activation Syndrome in the Pathogenesis of Hemophagocytic Lymphohistiocytosis"],"prefix":"10.7759","author":[{"given":"Omair","family":"Bseiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Zahdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obay","family":"Isayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seewar","family":"Mahagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Bseiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH","volume":"161","author":"Usmani GN","year":"2013","unstructured":"Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013, 161:609-22. 10.1111\/bjh.12293","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12138","article-title":"Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis","volume":"160","author":"Lehmberg K","year":"2013","unstructured":"Lehmberg K, Ehl S. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol. 2013, 160:275-87. 10.1111\/bjh.12138","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/107327481402100406","article-title":"Hereditary and acquired hemophagocytic lymphohistiocytosis","volume":"21","author":"Zhang L","year":"2014","unstructured":"Zhang L, Zhou J, Sokol L. Hereditary and acquired hemophagocytic lymphohistiocytosis. Cancer Control. 2014, 21:301-12. 10.1177\/107327481402100406","journal-title":"Cancer Control"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/jpn.JPN_140_16","article-title":"Hemophagocytic lymphohistiocytosis: a diagnostic conundrum","volume":"12","author":"Grzybowski B","year":"2017","unstructured":"Grzybowski B, Vishwanath VA. Hemophagocytic lymphohistiocytosis: a diagnostic conundrum. J Pediatr Neurosci. 2017, 12:55-60. 10.4103\/jpn.JPN_140_16","journal-title":"J Pediatr Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2017.1324599","article-title":"Case report: patient with unexplained high fever and pancytopenia","volume":"72","author":"De Schuyter K","year":"2017","unstructured":"De Schuyter K, Lodewyck T. Case report: patient with unexplained high fever and pancytopenia. Acta Clin Belg. 2017, 72:465-8. 10.1080\/17843286.2017.1324599","journal-title":"Acta Clin Belg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0740-3","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a review of literature","volume":"30","author":"Mehta RS","year":"2013","unstructured":"Mehta RS, Smith RE. Hemophagocytic lymphohistiocytosis (HLH): a review of literature. Med Oncol. 2013, 30:740. 10.1007\/s12032-013-0740-3","journal-title":"Med Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","article-title":"Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis","volume":"139","author":"Rosado FG","year":"2013","unstructured":"Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013, 139:713-27. 10.1309\/AJCP4ZDKJ4ICOUAT","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.12.012","article-title":"Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis","volume":"89","author":"Parikh SA","year":"2014","unstructured":"Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014, 89:484-92. 10.1016\/j.mayocp.2013.12.012","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-5-432","article-title":"Haemophagocytic lymphohistiocytosis: an elusive syndrome","volume":"16","author":"Thomas W","year":"2016","unstructured":"Thomas W, Veer MV, Besser M. Haemophagocytic lymphohistiocytosis: an elusive syndrome. Clin Med (Lond). 2016, 16:432-6. 10.7861\/clinmedicine.16-5-432","journal-title":"Clin Med (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes--an update","volume":"28","author":"Janka GE","year":"2014","unstructured":"Janka GE, Lehmberg K. Hemophagocytic syndromes--an update. Blood Rev. 2014, 28:135-42. 10.1016\/j.blre.2014.03.002","journal-title":"Blood Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.06.007","article-title":"Pathogenesis of hemophagocytic lymphohistiocytosis","volume":"29","author":"Filipovich AH","year":"2015","unstructured":"Filipovich AH, Chandrakasan S. Pathogenesis of hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 2015, 29:895-902. 10.1016\/j.hoc.2015.06.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.207","article-title":"Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo","volume":"14","author":"K\u00e4gi D","year":"1996","unstructured":"K\u00e4gi D, Ledermann B, B\u00fcrki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 1996, 14:207-32. 10.1146\/annurev.immunol.14.1.207","journal-title":"Annu Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders","volume":"26","author":"Brisse E","year":"2015","unstructured":"Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015, 26:263-80. 10.1016\/j.cytogfr.2014.10.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.178","article-title":"Approach to hemophagocytic syndromes","volume":"2011","author":"Weitzman S","year":"2011","unstructured":"Weitzman S. Approach to hemophagocytic syndromes. Hematology Am Soc Hematol Educ Program. 2011, 2011:178-83. 10.1182\/asheducation-2011.1.178","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2010.00890.x","article-title":"Inherited defects in lymphocyte cytotoxic activity","volume":"235","author":"Pachlopnik Schmid J","year":"2010","unstructured":"Pachlopnik Schmid J, C\u00f4te M, M\u00e9nager MM, et al.. Inherited defects in lymphocyte cytotoxic activity. Immunol Rev. 2010, 235:10-23. 10.1111\/j.0105-2896.2010.00890.x","journal-title":"Immunol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.23.090506.123521","article-title":"Secretory mechanisms in cell-mediated cytotoxicity","volume":"23","author":"Stinchcombe JC","year":"2007","unstructured":"Stinchcombe JC, Griffiths GM. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol. 2007, 23:495-517. 10.1146\/annurev.cellbio.23.090506.123521","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2015.56971","article-title":"The role of natural killer cells in pathogenesis of autoimmune diseases","volume":"40","author":"Popko K","year":"2015","unstructured":"Popko K, G\u00f3rska E. The role of natural killer cells in pathogenesis of autoimmune diseases. Cent Eur J Immunol. 2015, 40:470-6. 10.5114\/ceji.2015.56971","journal-title":"Cent Eur J Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.medin.2014.05.002","article-title":"[Natural killer cell cytotoxic activity in critical pediatric patients with suspected hemophagocytic syndrome]","volume":"39","author":"Mart\u00ednez I","year":"2015","unstructured":"Mart\u00ednez I, Fern\u00e1ndez L, Valent\u00edn J, Castillo C, Chamorro C, P\u00e9rez-Mart\u00ednez A. [Natural killer cell cytotoxic activity in critical pediatric patients with suspected hemophagocytic syndrome]. Med Intensiva. 2015, 39:213-21. 10.1016\/j.medin.2014.05.002","journal-title":"Med Intensiva"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00335","article-title":"Human NK cell lytic granules and regulation of their exocytosis","volume":"3","author":"Krzewski K","year":"2012","unstructured":"Krzewski K, Coligan JE. Human NK cell lytic granules and regulation of their exocytosis. Front Immunol. 2012, 3:335. 10.3389\/fimmu.2012.00335","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014173","article-title":"Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes","volume":"5","author":"Nagai K","year":"2010","unstructured":"Nagai K, Yamamoto K, Fujiwara H, et al.. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLoS One. 2010, 5:e14173. 10.1371\/journal.pone.0014173","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2014.03.014","article-title":"Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity","volume":"325","author":"Meeths M","year":"2014","unstructured":"Meeths M, Chiang SC, L\u00f6fstedt A, M\u00fcller ML, Tesi B, Henter JI, Bryceson YT. Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity. Exp Cell Res. 2014, 325:10-7. 10.1016\/j.yexcr.2014.03.014","journal-title":"Exp Cell Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-441139","article-title":"Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease","volume":"121","author":"K\u00f6gl T","year":"2013","unstructured":"K\u00f6gl T, M\u00fcller J, Jessen B, et al.. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood. 2013, 121:604-13. 10.1182\/blood-2012-07-441139","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George MR","year":"2014","unstructured":"George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014, 5:69-86. 10.2147\/JBM.S46255","journal-title":"J Blood Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich AH","year":"2009","unstructured":"Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009, 127-31. 10.1182\/asheducation-2009.1.127","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-012-0210-7","article-title":"Hemophagocytic lymphohistiocytosis","volume":"30","author":"Narendra AM","year":"2014","unstructured":"Narendra AM, Varun Kumar G, Krishna Prasad A, Shetty M, Uppin MS, Srinivasan VR. Hemophagocytic lymphohistiocytosis. Indian J Hematol Blood Transfus. 2014, 30:204-7. 10.1007\/s12288-012-0210-7","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat P","year":"2017","unstructured":"Bhat P, Leggatt G, Waterhouse N, Frazer IH. Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity. Cell Death Dis. 2017, 8:e2836. 10.1038\/cddis.2017.67","journal-title":"Cell Death Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-016-0262-7","article-title":"Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis","volume":"42","author":"Chen Y","year":"2016","unstructured":"Chen Y, Wang Z, Luo Z, Zhao N, Yang S, Tang Y. Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis. Ital J Pediatr. 2016, 42:50. 10.1186\/s13052-016-0262-7","journal-title":"Ital J Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.02.018","article-title":"Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children","volume":"39","author":"Han XC","year":"2017","unstructured":"Han XC, Ye Q, Zhang WY, Tang YM, Xu XJ, Zhang T. Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children. J Crit Care. 2017, 39:72-7. 10.1016\/j.jcrc.2017.02.018","journal-title":"J Crit Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.473","article-title":"Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level","volume":"184","author":"Sornasse T","year":"1996","unstructured":"Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med. 1996, 184:473-83. 10.1084\/jem.184.2.473","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90332-8","article-title":"Lymphocyte responses and cytokines","volume":"76","author":"Paul WE","year":"1994","unstructured":"Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994, 76:241-51. 10.1016\/0092-8674(94)90332-8","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D'Andrea A","year":"1993","unstructured":"D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. J Exp Med. 1993, 178:1041-8. 10.1084\/jem.178.3.1041","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri G","year":"1995","unstructured":"Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995, 13:251-76. 10.1146\/annurev.iy.13.040195.001343","journal-title":"Annu Rev Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore KW","year":"1993","unstructured":"Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993, 11:165-90. 10.1146\/annurev.iy.11.040193.001121","journal-title":"Annu Rev Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91584-9","article-title":"Interleukin-10 production during septicaemia","volume":"343","author":"Marchant A","year":"1994","unstructured":"Marchant A, Deviere J, Byl B, De Groote D, Vincent JL, Goldman M. Interleukin-10 production during septicaemia. Lancet. 1994, 343:707-8. 10.1016\/S0140-6736(94)91584-9","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi Y","year":"1997","unstructured":"Osugi Y, Hara J, Tagawa S, et al.. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997, 89:4100-3.","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121233","article-title":"Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome","volume":"40","author":"Strippoli R","year":"2013","unstructured":"Strippoli R, Caiello I, De Benedetti F. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome. J Rheumatol. 2013, 40:761-7. 10.3899\/jrheum.121233","journal-title":"J Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse E","year":"2016","unstructured":"Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol. 2016, 174:203-17. 10.1111\/bjh.14147","journal-title":"Br J Haematol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0130-4","article-title":"Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome","volume":"15","author":"Bracaglia C","year":"2017","unstructured":"Bracaglia C, Prencipe G, De Benedetti F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J. 2017, 15:5. 10.1186\/s12969-016-0130-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli A","year":"2002","unstructured":"Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002, 14:548-52.","journal-title":"Curr Opin Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-015-1877-1","article-title":"Macrophage activation syndrome","volume":"83","author":"Sen ES","year":"2016","unstructured":"Sen ES, Clarke SL, Ramanan AV. Macrophage activation syndrome. Indian J Pediatr. 2016, 83:248-53. 10.1007\/s12098-015-1877-1","journal-title":"Indian J Pediatr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000093","article-title":"Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"26","author":"Weaver LK","year":"2014","unstructured":"Weaver LK, Behrens EM. Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol. 2014, 26:562-9. 10.1097\/BOR.0000000000000093","journal-title":"Curr Opin Rheumatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom AA","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016, 12:259-68. 10.1038\/nrrheum.2015.179","journal-title":"Nat Rev Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert GS","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies. Annu Rev Med. 2015, 66:145-59. 10.1146\/annurev-med-061813-012806","journal-title":"Annu Rev Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-016-0559-8","article-title":"Extremely high ferritinemia associated with haemophagocytic lympho histiocytosis (HLH)","volume":"32","author":"Verma N","year":"2017","unstructured":"Verma N, Chakraverty J, Baweja P, Girotra A, Chatterjee L, Chugh M. Extremely high ferritinemia associated with haemophagocytic lympho histiocytosis (HLH). Indian J Clin Biochem. 2017, 32:117-20. 10.1007\/s12291-016-0559-8","journal-title":"Indian J Clin Biochem"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron RQ","year":"2015","unstructured":"Cron RQ, Davi S, Minoia F, Ravelli A. Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol. 2015, 11:1043-53. 10.1586\/1744666X.2015.1058159","journal-title":"Expert Rev Clin Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100996","article-title":"An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"38","author":"Dav\u00ec S","year":"2011","unstructured":"Dav\u00ec S, Consolaro A, Guseinova D, et al.. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011, 38:764-8. 10.3899\/jrheum.100996","journal-title":"J Rheumatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1294-z","article-title":"Hemophagocytic lymphohistiocytosis: an update for nephrologists","volume":"48","author":"Filippone EJ","year":"2016","unstructured":"Filippone EJ, Farber JL. Hemophagocytic lymphohistiocytosis: an update for nephrologists. Int Urol Nephrol. 2016, 48:1291-304. 10.1007\/s11255-016-1294-z","journal-title":"Int Urol Nephrol"},{"key":"ref48","article-title":"Macrophage activation syndrome","volume":"65","author":"Raj PB","year":"2017","unstructured":"Raj PB, Harikrishnan BL, Mampilly R, Anand R. Macrophage activation syndrome. J Assoc Physicians India. 2017, 65:91-2.","journal-title":"J Assoc Physicians India"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/ar3843","article-title":"Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis","volume":"14","author":"Bode SF","year":"2012","unstructured":"Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012, 14:213. 10.1186\/ar3843","journal-title":"Arthritis Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.03.002","article-title":"Macrophage activation syndrome and cytokine-directed therapies","volume":"28","author":"Schulert GS","year":"2014","unstructured":"Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014, 28:277-92. 10.1016\/j.berh.2014.03.002","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131604-the-role-of-immune-mechanisms-inflammatory-pathways-and-macrophage-activation-syndrome-in-the-pathogenesis-of-hemophagocytic-lymphohistiocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:43Z","timestamp":1707508123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131604-the-role-of-immune-mechanisms-inflammatory-pathways-and-macrophage-activation-syndrome-in-the-pathogenesis-of-hemophagocytic-lymphohistiocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.33175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,31]]}}}